• 1
    Bingley PJ, Christie MR, Bonifacio E et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994; 43:130410.
  • 2
    Kulmala P, Rahko J, Savola K et al. Stability of autoantibodies and their relation to genetic and metabolic markers of Type I diabetes in initially unaffected schoolchildren. Diabetologia 2000; 43:45764.
  • 3
    Graham J, Hagopian WA, Kockum I et al. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 2002; 51:134655.
  • 4
    Groop LC, Bottazzo GF, Doniac D. Islet cell antibodies identify latent type 1 diabetes in patients aged 35–75 years at diagnosis. Diabetes 1986; 35:23741.
  • 5
    Rowley MJ, Mackay IR, Chen QY, Knowles WJ, Zimmet PZ. Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes 1992; 41:54851.
  • 6
    Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993; 42:35962.
  • 7
    Niskanen LK, Tuomi T, Karjalainen J, Groop LC, Uusitupa MI. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis. Diabetes Care 1995; 18:155765.
  • 8
    Turner R, Stratton I, Horton V et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 1997; 350:128893 [published erratum appears in Lancet 1998 January 31; 351 (9099): 376].
  • 9
    Hampe CS, Kockum I, Landin-Olsson M et al. GAD65 antibody epitope patterns of type 1·5 diabetic patients are consistent with slow-onset autoimmune diabetes. Diabetes Care 2002; 25:14812.
  • 10
    Hampe CS, Hammerle LP, Bekris L et al. Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes. J Clin Endocrinol Metab 2000; 85:46719.
  • 11
    Padoa CJ, Banga JP, Madec AM et al. Recombinant Fabs of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs. Diabetes 2003; 52:268995.
  • 12
    Falorni A, Gambelunghe G, Forini F et al. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus. J Clin Endocrinol Metab 2000; 85:30916.
  • 13
    Falorni A, Calcinaro F. Autoantibody profile and epitope mapping in latent autoimmune diabetes in adults. Ann NY Acad Sci 2002; 958:99106.
  • 14
    Ziegler B, Strebelow M, Rjasanowski I, Schlosser M, Ziegler M. A monoclonal antibody-based characterization of autoantibodies against glutamic acid decarboxylase in adults with latent autoimmune diabetes. Autoimmunity 1998; 28:618.
  • 15
    Kobayashi T, Tanaka S, Okubo M, Nakanishi K, Murase T, Lernmark A. Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes. J Clin Endocrinol Metab 2003; 88:476875.
  • 16
    Gilliam LK, Binder KA, Banga JP et al. Multiplicity of the antibody response to GAD65 in Type I diabetes. Clin Exp Immunol 2004; 138:33741.
  • 17
    Schlosser M, Banga JP, Madec AM et al. Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes. Diabetologia 2005; 48:92230.
  • 18
    Rolandsson O, Hagg E, Lernmark A. GAD65- and IA-2 autoantibodies in adults are associated with abnormal glucose tolerance but not necessarily with later appearance of Type 1 Diabetes. 59th Scientific Sessions, San Diego, 1999 [Abstract].
  • 19
    Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15:53953.
  • 20
    Falorni A, Grubin CE, Takei I et al. Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 1994; 19:11325.
  • 21
    Grubin CE, Daniels T, Toivola B et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994; 37:34450.
  • 22
    Kawasaki E, Yu L, Gianani R et al. Evaluation of islet cell antigen (ICA) 512/IA-2 autoantibody radioassays using overlapping ICA512/IA-2 constructs. J Clin Endocrinol Metab 1997; 82:37580.
  • 23
    Madec AM, Rousset F, Ho S et al. Four IgG anti-islet human monoclonal antibodies isolated from a type 1 diabetes patient recognize distinct epitopes of glutamic acid decarboxylase 65 and are somatically mutated. J Immunol 1996; 156:35419.
  • 24
    Jaume JC, Parry SL, Madec AM, Sonderstrup G, Baekkeskov S. Suppressive effect of glutamic acid decarboxylase 65-specific autoimmune B lymphocytes on processing of T cell determinants located within the antibody epitope. J Immunol 2002; 169:66572.
  • 25
    Schwartz HL, Chandonia JM, Kash SF et al. High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase. J Mol Biol 1999; 287:98399.
  • 26
    Tremble J, Morgenthaler NG, Vlug A et al. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase- 65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes. J Clin Endocrinol Metab 1997; 82:266470.
  • 27
    Hampe CS, Lundgren P, Daniels TL, Hammerle LP, Marcovina SM, Lernmark Å. A novel monoclonal antibody specific for the N-terminal end of GAD65. J Neuroimmunol 2001; 113:6371.
  • 28
    Hall TR Thomas JW Padoa CJ et al. Longitudinal epitope analysis of insulin-binding antibodies in type 1 diabetes. Clin Exp Immunol 2006; 146:914.
  • 29
    Padoa CJ, Crowther NJ, Thomas JW et al. Epitope analysis of insulin autoantibodies using recombinant Fab. Clin Exp Immunol 2005; 140:56471.
  • 30
    Andersson DK, Svardsudd K, Tibblin G. Prevalence and incidence of diabetes in a Swedish community 1972–87. Diabet Med 1991; 8:42834.